Goldan Keith A.

CIK 00014954115 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001495411

Recent Transactions

50 trades

Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-06-01$18.99/sh−1,177→ 139,252 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Common Stock
2026-04-01+32,751→ 32,751 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-02-09$21.03/sh−3,410→ 140,429 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-02-06$20.62/sh−2,082→ 143,839 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-02-04+21,500→ 115,171 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2026-02-04$20.43/sh+118,000→ 118,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-02-04+30,750→ 145,921 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-01-30$8.48/sh+1,219→ 93,671 total
Gift
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-12-01−1,224→ 92,452 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-07-31$8.43/sh+1,226→ 93,676 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-07-16$9.29/sh−1,296→ 92,450 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-05-19+3,000→ 93,746 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-02-10$15.50/sh−3,777→ 90,746 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2025-02-05$14.65/sh+110,500→ 110,500 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-02-05+18,500→ 71,123 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-02-05+23,400→ 94,523 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-06-14$20.03/sh+1,250→ 52,623 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-02-07+11,700→ 51,373 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2024-02-07$22.28/sh+70,000→ 70,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-02-07+35,000→ 39,673 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-01-31$17.42/sh+1,183→ 4,673 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-07-31$18.12/sh+862→ 3,490 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-06-13$22.31/sh−577→ 2,628 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-02-02$28.55/sh+110,000→ 110,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-06-13+3,205→ 3,205 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-06-13$15.60/sh+230,000→ 230,000 total
Sale
OptiNose, Inc.
Common Stock
2022-03-16$2.11/sh−4,617→ 141,726 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2022-01-11+85,095→ 85,095 total
Award
OptiNose, Inc.
Common Stock
2022-01-11+56,730→ 146,343 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2022-01-11+66,185→ 66,185 total
Sale
OptiNose, Inc.
Common Stock
2021-12-16$1.64/sh−580→ 89,613 total
Sale
OptiNose, Inc.
Common Stock
2021-09-16$2.79/sh−578→ 90,193 total
Sale
OptiNose, Inc.
Common Stock
2021-06-17$3.73/sh−576→ 90,771 total
Sale
OptiNose, Inc.
Common Stock
2021-03-15$3.92/sh−2,304→ 91,347 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2021-03-04$3.51/sh+80,000→ 80,000 total
Award
OptiNose, Inc.
Common Stock
2021-03-04+53,333→ 63,084 total
Purchase
OptiNose, Inc.
Common Stock
2020-09-23$3.90/sh+2,500→ 9,751 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2020-03-06$5.41/sh+45,850→ 45,850 total
Award
OptiNose, Inc.
Restricted Stock Units
2020-03-06+30,567→ 30,567 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2020-03-06$5.41/sh+45,850→ 45,850 total
Award
OptiNose, Inc.
Common Stock
2020-03-06+30,567→ 37,328 total
Award
OptiNose, Inc.
Common Stock
2019-12-31$6.13/sh+2,695→ 6,761 total
Award
OptiNose, Inc.
Common Stock
2019-06-28$5.64/sh+941→ 4,066 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2019-02-28+82,500→ 82,500 total
Award
OptiNose, Inc.
Common Stock
2018-06-29$13.60/sh+3,125→ 3,125 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2017-10-12+72,197→ 72,197 total
Award
Fibrocell Science, Inc.
Option to Purchase Common Stock
2016-03-01+200,000→ 200,000 total
Purchase
Fibrocell Science, Inc.
Common Stock
2015-08-11$6.33/sh+2,000→ 2,000 total
Disposition to Issuer
NUPATHE INC.
Stock option (right to buy)
2014-02-21$4.88/sh−99,704→ 0 total
Disposition to Issuer
NUPATHE INC.
Common Stock
2014-02-21$6.80/sh−147,191→ 0 total

Companies

Recent Filings

Address

730 THIRD AVENUE FLOOR 9

NEW YORK, NY, 10017

View on SEC.gov